HeartWare International Inc  

(Public, NASDAQ:HTWR)   Watch this stock  
Find more results for HTWR
81.66
+0.82 (1.01%)
Oct 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 80.63 - 82.03
52 week 70.16 - 105.84
Open 81.75
Vol / Avg. 100,400.00/155,414.00
Mkt cap 1.37B
P/E     -
Div/yield     -
EPS -2.69
Shares 17.00M
Beta -0.08
Inst. own 107%
Oct 30, 2014
Q3 2014 HeartWare International Inc Earnings Release - 9:30AM EDT - Add to calendar
Oct 30, 2014
Q3 2014 HeartWare International Inc Earnings Call - 8:00AM EDT - Add to calendar
Aug 14, 2014
HeartWare International Inc at Canaccord Genuity Growth Conference
Aug 7, 2014
HeartWare International Inc at Piper Jaffray Heartland Summit
Jul 31, 2014
Q2 2014 HeartWare International Earnings Release
Jul 31, 2014
Q2 2014 HeartWare International Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 11.93% -28.52%
Operating margin 18.56% -22.87%
EBITD margin - -19.48%
Return on average assets 7.91% -18.64%
Return on average equity 17.08% -44.46%
Employees 569 -
CDP Score - -

Address

205 NEWBURY STREET
FRAMINGHAM, MA 01701
United States - Map
+1-508-7390841 (Phone)
+1-508-7390948 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Heartware International, Inc. (HeartWare) develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of advanced heart failure. The HeartWare Ventricular Assist System (the HeartWare System), which includes a ventricular assist device (VAD), or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients in the advanced stage of heart failure. The core of the HeartWare System is a continuous flow blood pump, the HVAD Pump, which is a full-output device capable of pumping up to 10 liters of blood per minute. The HeartWare System is designed to be implanted adjacent to the heart, avoiding the abdominal surgery generally required to implant similar devices. In December 2013, HeartWare International Inc acquired CircuLite, Inc.

Officers and directors

C. Raymond Larkin Jr. Independent Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Douglas Evan Godshall President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Seth Loring Harrison M.D. Deputy Chairman of the Board
Age: 54
Bio & Compensation  - Reuters
Peter F. McAree Chief Financial Officer, Senior Vice President, Treasurer
Age: 49
Bio & Compensation  - Reuters
Jeffrey A. LaRose Executive Vice President, Chief Scientific Officer
Age: 52
Bio & Compensation  - Reuters
Lawrence Knopf Senior Vice President, General Counsel, Company Secretary
Age: 52
Bio & Compensation  - Reuters
James Schuermann Senior Vice President - Sales and Marketing
Age: 45
Bio & Compensation  - Reuters
Robert Yocher Senior Vice President - Regulatory & Quality Assurance
Age: 63
Bio & Compensation  - Reuters
Katrin Leadley M.D. Chief Medical Officer
Bio & Compensation  - Reuters
Timothy Joseph Barberich Independent Director
Age: 66
Bio & Compensation  - Reuters